Our results suggest that treatments that specifically palliate the downregulation of Ldlr mRNA by LEC preserve the integrity of the lymphatic endothelium and sustain lymphatic function in chronic inflammatory conditions such as atherosclerosis. This evidence concerns the gene LDLR and atherosclerosis.